New drugs for treating dyslipidemias. From small molecules to small interfering RNAs Lluís Masana; Daiana Ibarretxe;

How to achieve LDL cholesterol goals with the funding criteria for new lipid-lowering drugs? Antón González-Guerrero; Elisenda Climent; David Benaiges; Juan Pedro Botet;

Lipoprotein (a) is a predictor of non-achievement of LDL-C goals in patients with chronic heart disease José Javier Gómez-Barrado; Paula Gómez-Turégano; María Beltrán Moreno; Ana Isabel Fernández-Chamorro; Benjamín Roque Rodríguez; Zineb Kounka;